• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Sedative-Hypnotic Drugs
Sedative-Hypnotic Drugs

... Many of the older sedative hypnotics, such as the barbiturates, will induce coma and death due to profound CNS depression if a patient significantly overdoses on their medication. In fact, overdosing on a sedative-hypnotic is a fairly popular method for attempting suicide. On the other hand, at acute ...
CURRENT STATUS OF DESIGNER DRUGS
CURRENT STATUS OF DESIGNER DRUGS

...  Title II of Comprehensive Drug Abuse Prevention and Control Act of 1970  Scheduled Drugs – I, II, III, IV, V  Schedule depends on medical utility and abuse potential ...
Antimicrobial Medications
Antimicrobial Medications

... Includes bacterial species Streptomyces and Bacillus as well as fungi Penicillium and Cephalosporium ...
File - Lindsay Social Studies
File - Lindsay Social Studies

... These approaches to treatment assume that there is an underlying physiological reason for the disturbed behavior. They treat only the symptoms of the disorders; they do not remove the causes of the disorders. Click the mouse button or press the Space Bar to display the answer. ...
Review of Basic Reference (1) Section
Review of Basic Reference (1) Section

...  Volume II – Advice for the patients  Volume III – Approved Drug Products and Legal Requirements Index: Indication / Generic, brand, common name US and Canada Published annually. Monthly Updates Online http://uspdi.micromedex.com/ ...
gastrointestinal drugs2014
gastrointestinal drugs2014

... 2. Laxatives that work osmotically 2) Lactulose 乳果糖; In the small bowel, it is resistant to hydrolysis and has an osmotic effect. In the large intestine, lactulose is acted upon by the endogenous flora with the production of lactic acid乳酸, Lactic acid also has an osmotic effect. It is used to reduce ...
Cross Addictions and Safe Medications
Cross Addictions and Safe Medications

... One of the relapse pathways we struggle with in chemical and alcohol dependencies is exposing the mesolimbic system or the hypothalamus to drugs or chemicals that can lead to a return to the primary drug of dependency. This is commonly referred to as cross-addiction. For example, you may realize tha ...
POTENTIAL DRUG ABUSE - Canadian Society of Addiction Medicine
POTENTIAL DRUG ABUSE - Canadian Society of Addiction Medicine

... • Calming obsessions from consumption; • Appease the "crash" post-consumption ...
Greenlees-web1
Greenlees-web1

... What Do They Actually DO at CVM... • Evaluate data submitted by pharmaceutical sponsors to demonstrate their veterinary drug (or additive for the animal food) is safe and effective •Present evaluations to pharmaceutical sponsors and, when appropriate, negotiate approaches to address Agency concerns ...
Postgraduate Course ERS Copenhagen 2005 The side
Postgraduate Course ERS Copenhagen 2005 The side

... effects. What is the truth? Modern anti-TB chemotherapy regimens have been in use for >30 years. However, the frequency of severe complications is not well known, probably due to lack of notification and under-reporting. It is clear that many patients have adverse reactions which complicate treatmen ...
Methods - ResearchGate
Methods - ResearchGate

... used in the hypersensitive test( allergic reaction) or the screening of anti-asthmatic drug. 5)rabbit: we are very familiar with rabbit, it is often used too but a little expensive. Its body temperature is very stable. So it is the assigned animal in the pyrogen test during the quality control of dr ...
Distribution of drugs
Distribution of drugs

... Chlorthalidone (a thiazide diuretic) binds to carbonic anhydrase in RBC strongly and accumulates in RBC 70 fold over plasma Chlorthalidone is relatively lipophilic and thus it can diffuse into RBC. As thiazides in general, chlorthalidone can also bind to carbonic anhydrase. Strong binding of this dr ...
Factors affecting drug metabolism
Factors affecting drug metabolism

... mRNA which leads to overproduction of these enzymes in the liver and other extra-hepatic tissues.  Enzyme induction: is the process by which the rate of synthesis of an enzyme is increased relative to the un-induced organism ...
RadioPharmaceuticals
RadioPharmaceuticals

... Transdermal medication delivers a steady infusion of a drug over an extended period of time. Adverse effects or therapeutic failures frequently associated with intermittent dosing can also be avoided. Transdermal delivery can increase therapeutic value of many drugs by avoiding specific problems a ...
No End in Sight: The Abuse of Prescription Narcotics
No End in Sight: The Abuse of Prescription Narcotics

... meaning that doctors should routinely ask about pain as part of any physical exam, not wait until the patient volunteers this information, and treat it accordingly. This report made headlines nationwide; Time magazine featured it on its cover. ...
File
File

... Over expression of the target enzyme InhA. Cross resistance may occur between isoniazid and ethionamide. Pharmacokinetics: Isoniazid is readily absorbed after oral administration. Absorption is impaired if isoniazid is taken with food, particularly high-fat meals. ...
Drug Nomenclature
Drug Nomenclature

... • Each dose of medication, give as soon as possible after it is given • Intentional or inadvertent omitted drugs • Refused drugs • Medication errors ...
Pharmaceutical Slides - Public Health and Social Justice
Pharmaceutical Slides - Public Health and Social Justice

... • 50% took at least one prescription drug » 7% took 5 or more • 14% took herbal supplements (16% of prescription drug users) ...
2015 PK and PD
2015 PK and PD

... Immune-modulating agents ...
SuperTarget goes quantitative: update on drug–target interactions
SuperTarget goes quantitative: update on drug–target interactions

... affinity data. We consider a drug–target relation as a specific interaction of a small chemical compound, which could be used to treat or diagnose a disease. Thus, SuperTarget now enables scientists to carry out not only qualitative but also quantitative analysis of drug–target interactions. DATA SET ...
Ensemble Therapeutics Presents Oral Efficacy of First-in
Ensemble Therapeutics Presents Oral Efficacy of First-in

... within the company’s therapeutic focus areas of oncology and immuno-inflammatory diseases. Concurrently the company is advancing other drug programs on behalf of its partners. About Ensemblins Ensemblins™ are a new class of synthetic macrocycles developed by Ensemble using its proprietary chemistry ...
anterior segment ophthalmic Pharmaceuticals
anterior segment ophthalmic Pharmaceuticals

... aSummary of the compounds that are currently in phase 3 clinical trials for which studies may be complete and that may enter the market within the next few years. Antiinflammatory Drugs Mapracorat is under development by Bausch + Lomb. This selective glucocorticoid receptor agonist blocks the produc ...
Rodney Ferry testimony - Oregon Legislative Information System
Rodney Ferry testimony - Oregon Legislative Information System

... However WHO also states: “The development of AMR is a natural phenomenon. However, certain human actions accelerate the emergence and spread of AMR. The inappropriate use of antimicrobial drugs, including in animal husbandry, favors the emergence and selection of resistant strains, and poor infectio ...
Diversity Analysis - ACS Division of Chemical Information
Diversity Analysis - ACS Division of Chemical Information

... other datasets examined here. • Pub-like Actives are, on average, smaller, less complex, ...
MCP Gastrointestinal & Genitourinary Drugs
MCP Gastrointestinal & Genitourinary Drugs

... – PEG bowel prep: fill jug with water, drink every 10 minutes until 4L is consumed, or rectal effluent is clear. Chilling drink helps taste. – Lactulose: take max 60ml liquid/day – Senna: recommended 15mg daily, once daily doses should be taken at ...
< 1 ... 79 80 81 82 83 84 85 86 87 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report